Menu
Home
GPcardio CVD, CKD & T2D About EPCCS About IPCCS NCD Academy EACH WONCA World 2025
EPCCS
About EPCCS Connected Societies GPcardio About IPCCS
Education
Lipid Management in ... Cardio Renal Update Cardiovascular Updat... The EU Cardiovascula... Cardiovascular Disea... Managing CV risk in ...
Resources
Practice Guidance Meeting reports STRATIFYHF Recent News Video updates WONCA World 2025
Literature
Left Atrial Appendag... 26 Mar. Novel cardiovascular... 26 Mar. Systemic Inflammatio... 24 Mar. Use of Coronary Arte... 16 Mar. 2026 ACC/AHA Guideli... 13 Mar. Off-label underdosin... 12 Mar. Semaglutide promotes... 9 Mar. Effect of baxdrostat... 7 Mar. More Literature

Mar. 1, 2026

High-Dose Influenza Vaccination in Atherosclerotic Cardiovascular Disease

A Multinational Pooled Analysis of DANFLU-2 and GALFLU (FLUNITY-HD)

Manan Pareek, Niklas Dyrby Johansen, Daniel Modin et al. - JACC

This multinational pooled analysis of the DANFLU-2 and GALFLU trials evaluated the effect of high-dose versus standard-dose influenza vaccination on cardiovascular outcomes in patients with atherosclerotic cardiovascular disease, addressing whether enhanced immunogenicity translates to better cardiovascular protection.

Summary

Publication date: Available online 18 February 2026Source: JACC

Source